☰

Nicholas T. Woods, Ph.D. - Publications

Affiliations: 
2008 University of South Florida, Tampa, FL, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kour S, Rana S, Kubica SP, Kizhake S, Ahmad M, Muñoz-Trujillo C, Klinkebiel D, Singh S, Mallareddy JR, Chandra S, Woods NT, Karpf AR, Natarajan A. Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells. The Journal of Biological Chemistry. 101890. PMID 35378132 DOI: 10.1016/j.jbc.2022.101890  0.331
2021 Mendoza-Fandiño G, Lyra PCM, Nepomuceno TC, Harro CM, Woods NT, Li X, Rangel LB, Carvalho MA, Couch FJ, Monteiro ANA. Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. European Journal of Human Genetics : Ejhg. PMID 34803163 DOI: 10.1038/s41431-021-01005-6  0.807
2019 Krieger KL, Hu WF, Ripperger T, Woods NT. Functional Impacts of the BRCA1-mTORC2 Interaction in Breast Cancer. International Journal of Molecular Sciences. 20. PMID 31771139 DOI: 10.3390/ijms20235876  0.365
2019 Hu WF, Krieger KL, Lagundžin D, Li X, Cheung RS, Taniguchi T, Johnson KR, Bessho T, Monteiro ANA, Woods NT. CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discovery. 5: 105. PMID 31240132 DOI: 10.1038/S41420-019-0185-3  0.571
2019 Krieger KL, Hu W, Ripperger T, Woods NT. Abstract 1716: Evaluating the functional impacts of the BRCA1-mTORC2 interaction in breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1716  0.391
2018 Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder S, et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research. PMID 30487138 DOI: 10.1158/0008-5472.Can-17-3864  0.74
2017 Harro CM, Mendoza-Fandino G, Woods NT, Li X, Couch FJ, Monteiro AN. Abstract 1306: Two distinct regulatory mechanisms underlie estrogen receptor negative breast cancer susceptibility at the 2p23.2 locus Epidemiology. 77: 1306-1306. DOI: 10.1158/1538-7445.Am2017-1306  0.389
2016 Woods NT, Baskin R, Golubeva V, Jhuraney A, De-Gregoriis G, Vaclova T, Goldgar DE, Couch FJ, Carvalho MA, Iversen ES, Monteiro AN. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine. 1. PMID 28781887 DOI: 10.1038/Npjgenmed.2016.1  0.758
2016 Vaclová T, Woods NT, Megías D, Gomez-Lopez S, Setién F, García Bueno JM, Macías JA, Barroso A, Urioste M, Esteller M, Monteiro AN, Benítez J, Osorio A. Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor Olaparib by a dominant negative effect. Human Molecular Genetics. PMID 27742776 DOI: 10.1093/Hmg/Ddw343  0.526
2016 Jhuraney A, Woods NT, Wright G, Rix L, Kinose F, Kroeger JL, Remily-Wood E, Cress WD, Koomen JM, Brantley SG, Gray JE, Haura EB, Rix U, Monteiro AN. PAXIP1 potentiates the combination of WEE1 inhibitor AZD1775 and platinum agents in lung cancer. Molecular Cancer Therapeutics. PMID 27196765 DOI: 10.1158/1535-7163.Mct-15-0182  0.783
2016 Buckley M, Gjyshi A, Mendoza-Fandiño G, Baskin R, Carvalho RS, Carvalho MA, Woods NT, Monteiro AN. Enhancer scanning to locate regulatory regions in genomic loci. Nature Protocols. 11: 46-60. PMID 26658467 DOI: 10.1038/Nprot.2015.136  0.743
2016 Gjyshi A, Mendoza-Fandino G, Woods N, Tyrer J, Lawrenson K, Buckley M, Shen H, Carvalho R, Seo J, Phelan C, Freedman M, Goode E, Sellers T, Gayther S, Pharoah P, et al. Abstract PR15: MYC distal enhancers underlie ovarian cancer susceptibility in the 8q24.21 locus. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Pr15  0.792
2015 Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Scientific Reports. 5: 17367. PMID 26610392 DOI: 10.1038/Srep17367  0.638
2015 Woods NT, Monteiro AN, Thompson ZJ, Amankwah EK, Naas N, Haura EB, Beg AA, Schabath MB. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients. Molecular Carcinogenesis. 54: E172-84. PMID 25597281 DOI: 10.1002/Mc.22275  0.576
2015 Woods NT, Jhuraney A, Monteiro AN. Incorporating computational resources in a cancer research program. Human Genetics. 134: 467-78. PMID 25324189 DOI: 10.1007/S00439-014-1496-3  0.749
2015 Baskin R, Woods N, Mendoza-Fandino G, Forsyth P, Egan K, Monteiro A. Abstract 3951: Functional analysis of the 11q23.3 glioma susceptibility locus Cancer Research. 75: 3951-3951. DOI: 10.1158/1538-7445.Am2015-3951  0.66
2014 Carvalho RS, Fernandes VC, Nepomuceno TC, Rodrigues DC, Woods NT, Suarez-Kurtz G, Chammas R, Monteiro AN, Carvalho MA. Characterization of LGALS3 (galectin-3) as a player in DNA damage response. Cancer Biology & Therapy. 15: 840-50. PMID 24755837 DOI: 10.4161/Cbt.28873  0.779
2014 Vaclova T, Woods NT, Setién F, Bueno JMG, Macías JA, Barroso A, Urioste M, Esteller M, Monteiro ANA, Benítez J, Osorio A. Abstract 5483: Implications of the type ofBRCA1germline mutation in the treatment of patients with hereditary breast cancer Cancer Research. 74: 5483-5483. DOI: 10.1158/1538-7445.Am2014-5483  0.374
2014 Buckley MA, Shen HC, Mendoza-Fandino GA, Woods NT, Gjyshi A, French J, Lawrenson K, Song H, Tyrer J, Carvalho RS, Valle A, Chen A, Yoder S, Bloom G, Tsai Y, et al. Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation ofBNC2as a mechanism in ovarian cancer predisposition Cancer Research. 74: 3285-3285. DOI: 10.1158/1538-7445.Am2014-3285  0.802
2014 Jhuraney A, Woods NT, Kinose F, Cress DW, Gray JE, Haura EB, Rix U, Monteiro AN. Abstract 2414: Overexpression of PAXIP1 potentiates WEE1 inhibitor action in lung cancer cells Cancer Research. 74: 2414-2414. DOI: 10.1158/1538-7445.Am2014-2414  0.79
2013 Tulchin N, Ornstein L, Dikman S, Strauchen J, Jaffer S, Nagi C, Bleiweiss I, Kornreich R, Edelmann L, Brown K, Bodian C, Nair VD, Chambon M, Woods NT, Monteiro AN. Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell International. 13: 70. PMID 23855721 DOI: 10.1186/1475-2867-13-70  0.622
2013 Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Woods N, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566  0.625
2012 Woods NT, Mesquita RD, Sweet M, Carvalho MA, Li X, Liu Y, Nguyen H, Thomas CE, Iversen ES, Marsillac S, Karchin R, Koomen J, Monteiro AN. Charting the landscape of tandem BRCT domain-mediated protein interactions. Science Signaling. 5: rs6. PMID 22990118 DOI: 10.1126/Scisignal.2002255  0.753
2012 Gerloff DL, Woods NT, Farago AA, Monteiro AN. BRCT domains: A little more than kin, and less than kind. Febs Letters. 586: 2711-6. PMID 22584059 DOI: 10.1016/J.Febslet.2012.05.005  0.572
2011 Liu Y, Woods NT, Kim D, Sweet M, Monteiro AN, Karchin R. Yeast two-hybrid junk sequences contain selected linear motifs. Nucleic Acids Research. 39: e128. PMID 21785140 DOI: 10.1093/Nar/Gkr600  0.507
2011 Woods NT, Nguyen H, Carvalho M, Li X, Dapic V, Monteiro A. Abstract 3892: Discovery and analysis of COMMD1 in the DNA damage response network Cancer Research. 71: 3892-3892. DOI: 10.1158/1538-7445.Am2011-3892  0.771
2010 Mesquita RD, Woods NT, Seabra-Junior ES, Monteiro AN. Tandem BRCT Domains: DNA's Praetorian Guard. Genes & Cancer. 1: 1140-6. PMID 21533002 DOI: 10.1177/1947601910392988  0.599
2010 Tulchin N, Chambon M, Juan G, Dikman S, Strauchen J, Ornstein L, Billack B, Woods NT, Monteiro AN. BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines. The American Journal of Pathology. 176: 1203-14. PMID 20075200 DOI: 10.2353/Ajpath.2010.081063  0.76
2009 Yamaguchi H, Woods NT, Piluso LG, Lee HH, Chen J, Bhalla KN, Monteiro A, Liu X, Hung MC, Wang HG. p53 acetylation is crucial for its transcription-independent proapoptotic functions. The Journal of Biological Chemistry. 284: 11171-83. PMID 19265193 DOI: 10.1074/Jbc.M809268200  0.66
2008 Yamaguchi H, Woods NT, Dorsey JF, Takahashi Y, Gjertsen NR, Yeatman T, Wu J, Wang HG. SRC directly phosphorylates Bif-1 and prevents its interaction with Bax and the initiation of anoikis. The Journal of Biological Chemistry. 283: 19112-8. PMID 18474606 DOI: 10.1074/Jbc.M709882200  0.527
2007 Woods NT, Yamaguchi H, Lee FY, Bhalla KN, Wang HG. Anoikis, initiated by Mcl-1 degradation and Bim induction, is deregulated during oncogenesis. Cancer Research. 67: 10744-52. PMID 18006817 DOI: 10.1158/0008-5472.Can-07-3148  0.576
2007 Ren Y, Chen Z, Chen L, Woods NT, Reuther GW, Cheng JQ, Wang HG, Wu J. Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL. The Journal of Biological Chemistry. 282: 36463-73. PMID 17942397 DOI: 10.1074/Jbc.M705789200  0.531
Show low-probability matches.